Stay updated on XmAb®20717 in Selected Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the XmAb®20717 in Selected Solid Tumors Clinical Trial page.

Latest updates to the XmAb®20717 in Selected Solid Tumors Clinical Trial page
- Check6 days agoChange DetectedAdded Revision: v3.5.2 to the history and removed Revision: v3.5.0.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check35 days agoChange DetectedRevision history updated to add v3.5.0 and remove v3.4.3.SummaryDifference0.1%

- Check42 days agoChange DetectedThe header revision was updated from v3.4.2 to v3.4.3. No other content changes are visible.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision: v3.4.2 was added to the history, and older notices (lapse in government funding warning and Revision: v3.4.1) were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check77 days agoChange DetectedThe page now displays a site-wide notice about government funding and operating status, and the revision tag was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check85 days agoChange DetectedGlossary toggle added and color-coded highlights (green for additions, red crossed-out for deletions) improve interpretation of changes. The revision label is updated to v3.4.0.SummaryDifference0.9%

Stay in the know with updates to XmAb®20717 in Selected Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XmAb®20717 in Selected Solid Tumors Clinical Trial page.